drugset / Trial / NCT01023360

Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay

NCT01023360

CrossoverOpen-labelScreening

Summary

Currently, drugs commonly used for antiplatelet are aspirin and clopidogrel when encountering stroke or coronary heart disease. In this study, we would use VASP assay and thromboelastograph with platelet mapping assay kit to evaluate the antiplatelet resistance in general population and the relationship between clopidogrel and proton pump inhibitor.

Timeline

Start
2008-05
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg Oral
Subject Esomeprazole Small molecule 40 mg Oral
Subject Pantoprazole Other / unclassified 40 mg Oral
Subject Rabeprazole Small molecule 20 mg Oral

Indications

No indication recorded.